)
)
Molecure Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Molecure S A
Access all reports
Molecure S.A. is a biotechnology company focused on the discovery and development of small molecule therapies for the treatment of inflammatory and fibrotic diseases, as well as cancer. The company leverages its proprietary research platforms to identify novel drug targets and advance its pipeline of investigational treatments. The company is headquartered in Warsaw, Poland, and its shares are listed on the WSE.
Key slides for Molecure S A
Investor Presentation
Molecure S A
Investor Presentation
Molecure S A
Latest articles
)
Axon: Making Bullets Obsolete
Axon transformed the TASER from a struggling invention into a $50B public safety giant, redefining policing with tech-driven solutions.
21 Feb 2025
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
Ticker symbol
MOC
Country
🇵🇱 Poland